MD Stock Predictions
| Recent MD Stock Price | MD Stock Predictions | |
| $14.05 |  +14.38% |
$16.07 |
| Recent MD Analyst Ratings Breakdown, Making MD Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 3 | 3 | 2 | 2 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 5 | 5 | 5 | 5 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 2.25 | 2.25 | 2.43 | 2.43 |
For the MD stock predictions from the analysts covering Pediatrix Medical Group Inc, we have collected all of the individual MD stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering MD (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MD stock predictions may vary widely, another useful metric to consider is the median MD stock prediction, which represents the price at which half of the analysts
made MD stock predictions that were higher and half made MD stock predictions that were lower. This makes for a different take on the MD stock predictions out there, as compared to average or mean.
And that median across all the individual MD stock predictions was: $15.0 as of 2025-02-18.
The very highest of the MD stock predictions for one year price target was $18.0, while the very lowest of the MD stock predictions in the analyst group was
$15.0 (with a standard deviation of $1.426). Get the latest Zacks research report on MD — FREE
Find out: MD next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• BOKF Stock Predictions
• BJRI Stock Predictions
• OSBC Stock Predictions
• TRVN Stock Predictions
• OPBK Stock Predictions
• STAR Stock Predictions
• KDMN Stock Predictions
• ATHM Stock Predictions
• SNE Stock Predictions
|
||||||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
 
|
Buy (2.75 out of 4) 17th percentile
(ranked lower than approx. 83% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
